ISSN: 0961-2033

Journal Home

Journal Guideline

Lupus Q2 Unclaimed

SAGE Publications Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Lupus is a journal indexed in SJR in Rheumatology with an H index of 118. It has an SJR impact factor of 0,812 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,812.

Lupus focuses its scope in these topics and keywords: lupus, systemic, erythematosus, response, presenting, syndrome, review, antiphospholipid, factor, follow, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Rheumatology (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,812

SJR Impact factor

118

H Index

193

Total Docs (Last Year)

743

Total Docs (3 years)

6582

Total Refs

1643

Total Cites (3 years)

687

Citable Docs (3 years)

1.99

Cites/Doc (2 years)

34.1

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Rheumatic Disease Clinics of North America Q2
Rheumatology International Q2
Autoimmunity Highlights Q2
Clinical and Experimental Rheumatology Q2
Clinical Rheumatology Q2

Compare this journals

Aims and Scope

Best articles by citations

Dobutamine stress echocardiography in women with systemic lupus erythematosus: increased occurrence of left ventricular outflow gradient

Responsiveness of peripheral blood B cells to recombinant CD40 ligand in patients with systemic lupus erythematosus

Multitarget therapy of mycophenolate mofetil and cyclosporine A for induction treatment of refractory lupus nephritis

Anti-beta2-glycoprotein I Antibody: Specificity and Clinical Significance

Effector and predisposing genes in murine lupus

Clinical and immunological manifestations in 134 Puerto Rican patients with systemic lupus erythematosus

Flares in lupus nephritis: Incidence, impact on renal survival and management

Polymorphisms of the human prolactin gene - implications for production of lymphocyte prolactin and systemic lupus erythematosus

Mucocutaneous disease in Arabs with systemic lupus erythematosus: Clinical expression and relevance to autoantibodies

Genetic susceptibility to lupus nephritis

Expression of complement regulatory proteins in diffuse proliferative glomerulonephritis

Members of the receptor for advanced glycation end products axis as potential therapeutic targets in patients with lupus nephritis

SHOW MORE ARTICLES

Outcome criteria for lupus nephritis trials: A critical overview

Impaired cytotoxic T lymphocyte activity in systemic lupus erythematosus following in vitro polyclonal T cell stimulation: a contributory role for non-T cells

Production of pathogenic antibodies: Cognate interactions between autoimmune T and B cells

Decreased expression of the p21ras stimulatory factor hSOS in PBMC from inactive SLE patients

Prolactin and systemic lupus erythematosus: prolactin secretion by SLE lymphocytes and proliferative (autocrine) activity

Role of HLA in congenital heart block: susceptibility alleles in mothers

Factors associated with chloroquine-induced retinopathy in rheumatic diseases

Prolactin in rheumatoid arthritis

Prolactin levels and antinuclear antibody profiles in women tested for connective tissue disease

Systemic lupus erythematosus presenting as acute symptomatic hypercalcemia

Lupus and the nervous system

Systemic lupus erythematosus with hepatic aneurysm, Valsalva sinus aneurysm and associated polyangiitis: aneurysmal wall remodeling with dense fibrosis and calcification mediated by residual smooth muscle cells